The Physiology of Fatigue in Patients With Chronic Liver Disease
2 other identifiers
observational
12
1 country
1
Brief Summary
Background: \- Fatigue is a common and often disabling symptom in people with chronic liver disease. Its causes are not well understood. Sleep disturbance may play a role in people with cirrhosis, but these factors have not been studied in people with other stages of liver disease. This study will look at the body's circadian rhythms (internal clock) to see if problems with these rhythms can contribute to fatigue. It will look at the causes and mechanisms of fatigue in people with chronic liver disease by comparing people with and without fatigue. Objectives: \- To study reasons for fatigue in people with chronic liver disease. Eligibility:
- \<TAB\>Individuals at least 18 years of age who have chronic liver disease.
- \<TAB\>Participants with or without fatigue may enroll. Design:
- Participants will be screened with a physical exam and medical history. They will have a 2-day inpatient stay for the study.
- For the 7 days before the inpatient stay, participants will keep a sleep diary. They will record any caffeine or alcohol consumption, medicines, exercise, and sleep or naps. They will also wear an actigraph to measure their activity levels.
- During the inpatient stay, participants will answer questions about fatigue and sleep habits. They will have regular blood tests for 24 hours. Their body temperature will also be monitored. During the night, they will have a sleep study to look at how well or poorly they sleep.
- Treatment will not be provided as part of this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2013
CompletedStudy Start
First participant enrolled
May 31, 2013
CompletedFirst Posted
Study publicly available on registry
June 4, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2018
CompletedNovember 23, 2018
November 20, 2018
2.3 years
May 31, 2013
November 21, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Circadian rythms
2-7 days
Eligibility Criteria
You may qualify if:
- Adults (age \>18) with chronic liver disease of any etiology
You may not qualify if:
- Treatment with medications or supplements frequently associated with fatigue, such as interferon (within the last four months), beta-blockers, calcium channel blockers, benzodiazepines, sedating antihistamines, antidepressants, antipsychotics, or melatonin. In select instances, patients using these medications may be enrolled if, in the opinion of the investigators, their fatigue is clearly unrelated to the medication.
- Untreated or uncontrolled comorbidities that influence fatigue, including thyroid disorders (TSH\>5 mcIU/mL), anemia (Hemoglobin\<11 g/dL), major depression, active substance abuse or other conditions as determined by the enrolling physician. Comorbidities that are adequately controlled will not exclude patients.
- Untreated sleep disorders such as obstructive sleep apnea or restless leg syndrome
- Decompensated cirrhosis (encephalopathy, gastrointestinal bleeding, ascites, bilirubin \>2) within the last six months
- Patients planning to travel outside the time zone during the study period
- Known or suspected significant gastrointestinal motility disorder, obstruction, or structuring disease
- Pregnancy, breastfeeding, or intention to become pregnant
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (3)
Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998 Jan;27(1):209-12. doi: 10.1002/hep.510270132.
PMID: 9425939BACKGROUNDGumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 1995 Oct 15;123(8):615-20. doi: 10.7326/0003-4819-123-8-199510150-00008.
PMID: 7677303BACKGROUNDKallman J, O'Neil MM, Larive B, Boparai N, Calabrese L, Younossi ZM. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci. 2007 Oct;52(10):2531-9. doi: 10.1007/s10620-006-9708-x. Epub 2007 Apr 4.
PMID: 17406828BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yaron Rotman, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Design
- Study Type
- observational
- Time Perspective
- OTHER
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2013
First Posted
June 4, 2013
Study Start
May 31, 2013
Primary Completion
September 11, 2015
Study Completion
November 20, 2018
Last Updated
November 23, 2018
Record last verified: 2018-11-20